Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia

scientific article published on 25 April 2016

Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1200/JCO.2015.64.5812
P932PMC publication ID4962704
P698PubMed publication ID27114598

P50authorElaine MardisQ5353251
Stephen P HungerQ64215088
Mignon L LohQ64215090
Ching-Hon PuiQ66385450
Sima JehaQ100677736
Meenakshi DevidasQ102141953
Deqing PeiQ114529747
Elizabeth A RaetzQ114529750
P2093author name stringRobert S Fulton
Mary V Relling
Chengcheng Liu
William E Evans
Cheng Cheng
Wenjian Yang
Naomi J Winick
William L Carroll
W Paul Bowman
Scott C Howard
Paul L Martin
Deepa Bhojwani
Kelly W Maloney
Leonard A Mattano
Colton Smith
Eric C Larsen
P2860cites workMutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type IIIQ24297629
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasisQ24337342
Treating childhood acute lymphoblastic leukemia without cranial irradiationQ24644599
Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme YQ24675338
A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutationsQ24805119
Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitisQ28145585
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitisQ30528817
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.Q32061751
Drug-induced pancreatitis: an updateQ33221158
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).Q33645760
The sequence and conformation of human pancreatic procarboxypeptidase A2. cDNA cloning, sequence analysis, and three-dimensional model.Q34321392
American College of Gastroenterology guideline: management of acute pancreatitisQ34360523
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemiaQ35015010
Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosisQ35209665
Protective effect of a microtubule stabilizer taxol on caerulein-induced acute pancreatitis in rat.Q35596569
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemiaQ35616085
Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria.Q35849447
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.Q35976588
Predicting asparaginase-associated pancreatitisQ36579699
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer InstitutQ36678136
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group studyQ36713493
Sequence kernel association tests for the combined effect of rare and common variantsQ36909285
Variants in CPA1 are strongly associated with early onset chronic pancreatitisQ37540036
The role of calcium in acute pancreatitisQ38036042
Asparaginase-associated pancreatitis in childrenQ38036389
Genetics of acute and chronic pancreatitisQ38122993
Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control studyQ38427548
Mutations of the cystic fibrosis gene in patients with chronic pancreatitisQ38502091
Pegaspargase-induced pancreatitisQ41722320
Pancreatic exocrine secretion in acute experimental pancreatitisQ42485711
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.Q42704205
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group studyQ43904527
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalQ44976795
Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.Q46540888
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.Q50670242
Latent onset of clinical pancreatitis in children receiving l-asparaginase therapyQ53775952
Mutations in the calcium-sensing receptor: A new genetic risk factor for chronic pancreatitis?Q60689172
Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginaseQ84577211
6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphomaQ85396912
Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocolQ87104417
P433issue18
P407language of work or nameEnglishQ1860
P921main subjectleukemiaQ29496
acute pancreatitisQ854573
P304page(s)2133-2140
P577publication date2016-04-25
P1433published inJournal of Clinical OncologyQ400292
P1476titleClinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia
P478volume34

Reverse relations

cites work (P2860)
Q38665804Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study
Q51620499Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol.
Q92672135Asparagine Synthetase Is Highly Expressed at Baseline in the Pancreas Through Heightened PERK Signaling
Q47792311Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment).
Q64244287Fed-Batch Production of L-Asparaginase II by Recombinant Strain
Q39262358Genome-Wide Association Studies of Chemotherapeutic Toxicities: Genomics of Inequality
Q46377291Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait.
Q91249010Global efforts toward the cure of childhood acute lymphoblastic leukaemia
Q38968891In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeutics
Q99616292Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion
Q33557148Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.
Q102068310Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study
Q45985775Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens.
Q50200720Questions on asparaginase-associated pancreatitis
Q90463690Somatic and germline genomics in paediatric acute lymphoblastic leukaemia
Q38922016Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances
Q64077397Trypsin-encoding variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report
Q38748699Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients

Search more.